NCT00729833View on ClinicalTrials.gov

Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors

PHASE1TerminatedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

August 31, 2011

Study Completion Date

April 30, 2013

Conditions
Advanced CancerAdvanced Solid Tumors
Interventions
DRUG

CP-751,871

CP-751,871 IV, every 3 weeks

DRUG

Sunitinib

Sunitinib - daily dosing

Trial Locations (4)

19111

Pfizer Investigational Site, Philadelphia

78229

Pfizer Investigational Site, San Antonio

90095

Pfizer Investigational Site, Los Angeles

90404

Pfizer Investigational Site, Santa Monica

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY